INTERNATIONAL PATENT: IMMORTA BIO, INC. FILES APPLICATION FOR "THERAPEUTIC USE OF AUTOLOGOUS PLURIPOTENT STEM CELL AND DIFFERENTIATED CELL EXOSOMES"

GENEVA, Aug. 13 -- IMMORTA BIO, INC. (7064 Fisher Island DriveMiami Beach, Florida 33109) filed a patent application (PCT/US2025/014201) for "THERAPEUTIC USE OF AUTOLOGOUS PLURIPOTENT STEM CELL AND DIFFERENTIATED CELL EXOSOMES" on Jan 31, 2025. With publication no. WO/2025/166297, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ICHIM, Thomas E. (c/o IMMORTA BIO, INC.7064 Fisher Island DriveMiami Beach, Florida 33109), REZNIK, Boris (c/o Immorta Bio, Inc.7064 Fisher Island DriveMiami Beach, Florida 33109), REZNIK, Gary (c/...